Key Takeaways
- Morgan Stanley elevated Synopsys (SNPS) to Overweight from Equal-Weight, maintaining a $500 price objective.
- The rating change reflects increased conviction in Ansys merger synergies and Design IP segment rebound.
- The firm highlights physical AI as a significant yet overlooked growth driver for Synopsys’ product suite.
- Synopsys surpassed fiscal Q3 2026 projections with non-GAAP EPS of $3.91 and revenue reaching $2.48 billion.
- Baird separately elevated SNPS to Outperform, establishing a $560 price objective.
Synopsys (SNPS) secured an endorsement from Morgan Stanley this Tuesday, with the investment bank elevating the shares to Overweight from Equal-Weight while maintaining its $500 price objective.
Analyst Lee Simpson issued the rating change as Morgan Stanley recalibrates its semiconductor sector positioning. “As DRAM nears a late-cycle turning point and valuation spreads expand, we’re adopting a more discerning stance,” Simpson explained.
SNPS shares were hovering near $393.84 when the research note published, declining approximately 5.4% during the session, which Morgan Stanley identified as a compelling entry opportunity following the recent selloff.
The investment bank had previously shifted Synopsys to Equal-Weight status earlier in the year, awaiting greater visibility on three critical factors: profitability metrics from the Ansys acquisition, a reacceleration to double-digit EDA expansion, and validation that the co-design platform carries strategic significance.
Morgan Stanley indicates it now possesses sufficient conviction across these dimensions to restore the Overweight recommendation.
Ansys Merger Progress and Physical AI Opportunity
Central to the investment thesis is the Ansys acquisition execution. Synopsys unveiled Multiphysics Fusion during Q3, representing the inaugural combined offering from both organizations, and Morgan Stanley anticipates management may revise revenue synergy projections at the forthcoming investor day.
The firm also contends the market is undervaluing how effectively Synopsys’ technology stack aligns with the physical AI movement. Simpson highlighted simulation capabilities that evaluate thermal characteristics, mechanical resilience, and fluid behavior as especially applicable to narrowing the simulation-to-reality divide.
The newly introduced Factory 2 IP framework, a tailored IP solution targeting hyperscalers and ASIC developers requiring specialized configurations, represents another focal point Morgan Stanley expects management to emphasize.
Synopsys delivered 46% revenue expansion over the trailing twelve months and maintains a gross profit margin of 83%. Based on InvestingPro analysis, the shares currently trade beneath their calculated fair value.
Quarterly Results Exceed Forecasts and Additional Analyst Actions
Synopsys’ fiscal Q3 2026 performance exceeded Wall Street projections. The organization delivered non-GAAP EPS of $3.91, surpassing the $3.67 Street estimate, on revenue of $2.48 billion compared to the anticipated $2.44 billion.
The company subsequently elevated its full-year guidance following the quarterly report. Benchmark maintained its Buy recommendation, with analyst Gary Mobley characterizing it as a “beat-and-raise” quarter.
Baird independently upgraded Synopsys to Outperform from Neutral, elevating its price target to $560. Baird emphasized an encouraging growth trajectory for fiscal 2027 and anticipates a restoration of double-digit organic revenue expansion.
Morgan Stanley simultaneously downgraded Infineon (IFNNY) to Equal-Weight from Overweight, reducing its price target to ā¬65 from ā¬81. The firm also lowered projections on ASML to ā¬1,700 from ā¬1,930 and BE Semiconductor to ā¬220 from ā¬260.
Simpson remarked regarding Infineon that “PSS projections appear overly optimistic and multiple emerging headwinds leave us lacking a definitive catalyst.”
Morgan Stanley’s $500 price objective on SNPS remains consistent with its prior forecast.





